← Evidence map

ArticleCancers2022

Ascorbate Plus Buformin in AML: A Metabolic Targeted Treatment.

Cristina Banella et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

12 papers cite it

2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 35626170